Summary
Northern blot analysis of human tissues has demonstrated the expression of the brain-type glucose transporter isoform (GLUT 3) in liver, muscle and fat, raising the possibility that this transporter isoform may play a role in the regulation of glucose disposal in these tissues in response to insulin. We have raised an anti-peptide antibody against the C-terminal 13 amino acids of the murine homologue of this transporter isoform, and determined its tissue distribution in mouse tissues and murine-derived cell lines. The antibodies recognise a glycoprotein of about 50 kilodaltons, expressed at high levels in murine brain. In contrast to human tissues, the expression of GLUT 3 in mice is restricted to the brain, and no immunoreactivity was observed in either liver, fat or muscle membranes, or in murine 3T3-L1 fibroblasts or adipocytes. In contrast, high levels of expression of this isoform were observed in the NG 108 neuroblastoma x glioma cell line, a hybrid cell derived from rat glioma and mouse neuroblastoma cells. Taken together, these data suggest that the expression of GLUT 3 in rodents is restricted to non-insulin responsive neuronal cells and hence it is likely that the factors regulating the expression of this transporter in rodents differ to those in humans.
Article PDF
Similar content being viewed by others
References
Gould GW, Bell GI (1990) Facultative glucose transporters: an expanding family. Trends Biochem Sci 15: 18–23
Mueckler M (1990) Glucose transporter family: implications for glucose homeostasis and diabetes. Diabetes 39: 6–11
Bell GI, Kayano T, Buse JB et al. (1990) Molecular biology of mammalian glucose transporters. Diab Care 13: 198–208
Birnbaum MJ (1989) Identification of a novel gene encoding an insulin-regulatable glucose transport protein. Cell 57: 305–315
James DE, Strube M, Mueckler M (1989) Molecular cloning and characterisation of an insulin-regulatable glucose transporter. Nature (London) 338: 83–87
Zorzano A, Wilkinson W, Kotlair, N et al. (1989) Insulin-regulated glucose uptake in rat adipocytes is mediated by two transporter isoforms present in at least two vesicle populations. J Biol Chem 264: 12358–12363
Calderhead DM, Kitagawa K, Tanner LI, Holman GD, Lienhard GE (1990) Insulin regulation of two glucose transporters in 3T3-L1 adipocytes. J Biol Chem 265: 13800–13808
Holman GD, Kozka IJ, Clark AE et al. (1990) Cell surface labelling of glucose transporter isoform GLUT 4 by bis-mannose photolabel. J Biol Chem 265: 18172–18279
Garvey WT, Heucksteadt TP, Birnbaum MJ (1989) Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus. Science 245: 60–63
Sivitz WI, DeSautel SL, Kayano T, Bell GI, Pessin JE (1989) Regulation of glucose transporter messenger RNA in insulin deficient states. Nature (London) 340: 72–74
Thorens B, Sarkar HK, Kaback HR, Lodish HF (1988) Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney and β-pancreatic islet cells. Cell 55: 281–290
Fukumoto H, Seino S, Imura H et al. (1988) Sequence, tissue-distribution and chromosomal localisation of mRNA encoding a human glucose transporter-like protein. Proc Natl Acad Sci USA 85: 5434–5438
Gould GW, Thomas HM, Jess TJ, Bell GI (1991) Expression of human glucose transporters in Xenopus oocytes: kinetic characterisation and substrate specificites of the erythrocyte, liver and brain isoforms. Biochemistry 30: 5139–5145
Kayano T, Fukumoto H, Eddy RL et al. (1988) Evidence for a family of human glucose transporter-like proteins: sequence and gene localisation of a protein expressed in fetal skeletal muscle and other tissues. J Biol Chem 263: 15245–15248
Nagamatsu S, Kornhauser JM, Burant CF, Seino S, Mayo KE, Bell GI (1992) Glucose transporter expression in brain: cDNA sequence of mouse GLUT 3, the brain facilitative glucose transporter isoform, and identification of sites of expression by in situ hybridisation. J Biol Chem 267: 467–472
Coleman DL (1978) Obesity and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14: 141–148
Tominaga M, Komiya I, Johnson JH et al. (1986) Loss of insulin response to glucose but not arginine during the development of autoimmune diabetes in BB/W rats: relationships to islet volume and glucose transport rate. Proc Natl Acad Sci USA 83: 9749–9753
Gibbs EM, Calderhead DM, Holman GD, Gould GW (1991) Phorbol ester on partially mimics the effects of insulin on glucose transport and glucose transporter translocation in 3T3-L1 adipocytes. Biochem J 275: 145–150
Gould GW, Lienhard GE (1989) Expression of a functional glucose transporter in Xenopus oocytes. Biochemistry 28: 9447–9452
Lerner RA (1981) Chemically synthesised peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci USA 78: 3403–3407
Pilkis SJ, Exton JH, Johnson RA, Park CR (1974) Effects of glucagon on cyclic AMP and carbohydrate metabolism in livers from diabetic rats. Biochim Biophys Acta 343: 250–267
Marchmont RJ, Ayad SR, Houslay MD (1981) Purification and properties of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes. Biochem J 195: 645–652
Frost SC, Lane MD (1985) Evidence for the involvement of vicinal sulphydryl groups in insulin-activated hexose transport in 3T3-L1 adipocytes. J Biol Chem 260: 2646–2652
Gould GW, Lienhard GE, Tanner LI, Gibbs EM (1989) Phenylarsine oxide stimulates hexose transport in 3T3-L1 adipocytes by a mechanism other than an increase in surface transporters. Arch Biochem Biophys 268: 264–275
Hamprecht B, Glasser T, Reiser G, Bayer E, Propst F (1985) Culture and characteristics of hormone-responsive neuroblastoma x glioma hybrid cells. Meth Enzymol 109: 316–341
Clark AE, Holman GD (1990) Exofacial labelling of the human erythrocyte glucose transporter with an azitrifluoroethyl benzoyl-substituted bis -mannose. Biochem J 269: 615–622
Vera JC, Rosen OR (1989) Functional expression of mammalian glucose transporters in Xenopus oocytes: evidence for cell dependent insulin-sensitivity. Mol Cell Biol 9: 4187–4195
Gould GW, Derechin V, James DE et al. (1989) Insulin-stimulated translocation of the HepG2/erythrocyte-type glucose transporter expressed in 3T3-L1 adipocytes. J Biol Chem 264: 2180–2184
Froehner SC, Davies A, Baldwin SA, Lienhard GE (1988) The blood-nerve barrier is rich in glucose transporter. J Neurocytol 17: 173–178
Clarke DD, Lajitha AL, Maker HS (1981) Intermediary metabolism. In: Siegel G, Agranoff B, Albers RW, Molinoff P (eds) Basic Neurochemistry, 4th Edition. Raven Press, New York, pp 541–564
Yano H, Seino Y, Inagaki N et al. (1991) Tissue distribution and species difference in the expression of the brain-type glucose transporter, GLUT 3. Biochem Biophys Res Comm 174: 470–477
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gould, G.W., Brant, A.M., Kahn, B.B. et al. Expression of the brain-type glucose transporter is restricted to brain and neuronal cells in mice. Diabetologia 35, 304–309 (1992). https://doi.org/10.1007/BF00401196
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401196